TY - JOUR
T1 - Analysis of regional cerebral blood flow in dogs, with an experimental microbubble-based US contrast agent
AU - Greenberg, Robert S.
AU - Taylor, George A.
AU - Stapleton, John C.
AU - Hillsley, Catherine A.
AU - Spinak, David
PY - 1996/10
Y1 - 1996/10
N2 - PURPOSE: To evaluate a perfluorochemical stabilized microbubble-based ultrasound (US) contrast agent (Imagent US, formulation AF0145) create regional cerebral blood flow (CBF) maps. MATERIALS AND METHODS: Intravenous injections of the contrast agent (0.16-0.20 mL/kg) were performed in four anesthetized dogs (9-14 kg). Serial coronal color-Doppler-amplitude and gray- scale US scans were obtained through a cranial window during injection of contrast material. Mean pixel intensity was analyzed on digitized images. Regional CBF was varied by modifying arterial partial pressure of carbon dioxide (PaCO2). Color-Doppler-amplitude and gray-scale mean pixel intensity and percentage change in mean pixel intensity after injection of contrast material were analyzed, by means of a bolus injection curve that plotted color mean pixel intensity per unit area versus time. RESULTS: Contrast material injection resulted in a statistically significant difference in color-Doppler-amplitude and gray-scale enhancement of brain. Color mean pixel intensity increased from 1.4 units ± 1 (standard error) to 122 units ± 6 in thalamus and from 9.7 units ± 4.0 to 107 units ± 9 in cortex (P < .0001). Gray-scale mean pixel intensity increased from 0.55 units ± 0.20 to 33 units ± 11 in thalamus and from 0.42 units ± .06 to 10.5 units ± 2.0 in cortex (P < .005). Correlation between the area under the color-Doppler-amplitude mean-pixel-intensity curve and regional CBF in thalamus and cortex was significant (r = .815, P < .0001). CONCLUSION: Color-Doppler-amplitude US can be used to create regional CBF maps and shows potential for noninvasive evaluation of CBF in the critically ill newborn.
AB - PURPOSE: To evaluate a perfluorochemical stabilized microbubble-based ultrasound (US) contrast agent (Imagent US, formulation AF0145) create regional cerebral blood flow (CBF) maps. MATERIALS AND METHODS: Intravenous injections of the contrast agent (0.16-0.20 mL/kg) were performed in four anesthetized dogs (9-14 kg). Serial coronal color-Doppler-amplitude and gray- scale US scans were obtained through a cranial window during injection of contrast material. Mean pixel intensity was analyzed on digitized images. Regional CBF was varied by modifying arterial partial pressure of carbon dioxide (PaCO2). Color-Doppler-amplitude and gray-scale mean pixel intensity and percentage change in mean pixel intensity after injection of contrast material were analyzed, by means of a bolus injection curve that plotted color mean pixel intensity per unit area versus time. RESULTS: Contrast material injection resulted in a statistically significant difference in color-Doppler-amplitude and gray-scale enhancement of brain. Color mean pixel intensity increased from 1.4 units ± 1 (standard error) to 122 units ± 6 in thalamus and from 9.7 units ± 4.0 to 107 units ± 9 in cortex (P < .0001). Gray-scale mean pixel intensity increased from 0.55 units ± 0.20 to 33 units ± 11 in thalamus and from 0.42 units ± .06 to 10.5 units ± 2.0 in cortex (P < .005). Correlation between the area under the color-Doppler-amplitude mean-pixel-intensity curve and regional CBF in thalamus and cortex was significant (r = .815, P < .0001). CONCLUSION: Color-Doppler-amplitude US can be used to create regional CBF maps and shows potential for noninvasive evaluation of CBF in the critically ill newborn.
KW - Cerebral blood vessels, US
KW - Cerebral blood vessels, flow dynamics
KW - Ultrasound (US), contrast media
UR - http://www.scopus.com/inward/record.url?scp=0029830664&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0029830664&partnerID=8YFLogxK
U2 - 10.1148/radiology.201.1.8816531
DO - 10.1148/radiology.201.1.8816531
M3 - Article
C2 - 8816531
AN - SCOPUS:0029830664
VL - 201
SP - 119
EP - 123
JO - Radiology
JF - Radiology
SN - 0033-8419
IS - 1
ER -